Harmoney (ASX:HMY) share price surges 12% on update

This comes after an update earlier today on the personal lender company's performance.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Harmoney Corp Ltd (ASX: HMY) share price surged more than 12% in early trade. The bullish price action comes after the company released an update earlier today.  

At the time of writing, shares in Harmoney are now trading up 7.84%, at $2.20. The Harmoney share price was up more than 12% earlier, after hitting an intra-day high of $2.30.

Let's take a look at what Harmoney announced and why investors are scrambling for the company's shares.

heavy lifting, lifting index, carrying weight, boy lifting dumbbell above his head

Image source: Getty Images

Harmoney shares soar on strong originations growth

Earlier today, Harmoney released an update on the company's performance for the second half of FY21.

The update was highlighted by a 144% increase in total new originations for the half. In addition, Harmoney noted that Australian new customer originations grew by 260% in the second half to $47 million.

Overall, Harmoney recorded total group originations of NZ$250 million, compared to $193 million in the first half. The company noted that growth in new customers could lead to a strong increase in repeat customer originations in the following six months.

Harmoney also noted group receivables of NZ$501 million, yielding a net interest margin of 11%. The company's Australian receivables also grew by 33% in the 6 months since December 2020.

Harmoney's CEO and Managing Director David Stevens noted;

"It's pleasing to see Harmoney's new customer originations have surpassed pre-COVID levels. New customer originations is a lead indicator for receivables growth as more customers become eligible for our 3Rs repeat program.".

In addition to its performance in the second half, Harmoney also alluded to forecasts for FY22. The company noted that group receivables are forecast to grow at significantly higher levels in the new financial year. The company cited higher new customer originations and the release of LibraTM 1.7 in Australia.

Harmoney also noted its strong capital position, with undrawn funding lines of NZ$216 million as at 30 June 2021.  

More on Harmoney

Harmoney is an online direct personal lender that operates across Australia and New Zealand. The company provides customers with unsecured personal loans of up to $70,000 that are easy to access and competitively priced.

Despite today's jubilant price action, the Harmoney share price remains more than 22% lower for the year.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »